1. Home
  2. ADPT vs UNF Comparison

ADPT vs UNF Comparison

Compare ADPT & UNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$28.51

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Unifirst Corporation

UNF

Unifirst Corporation

N/A

Current Price

$261.62

Market Cap

5.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
ADPT
UNF
Founded
2009
1936
Country
United States
United States
Employees
624
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.0B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
ADPT
UNF
Price
$28.51
$261.62
Analyst Decision
Strong Buy
Hold
Analyst Count
9
3
Target Price
$17.78
$238.33
AVG Volume (30 Days)
1.8M
291.0K
Earning Date
05-05-2026
04-01-2026
Dividend Yield
N/A
0.57%
EPS Growth
63.89
2.70
EPS
N/A
4.11
Revenue
$276,976,000.00
$1,696,489,000.00
Revenue This Year
$3.98
$3.69
Revenue Next Year
$22.72
$3.53
P/E Ratio
N/A
$63.66
Revenue Growth
54.77
6.63
52 Week Low
$12.00
$147.66
52 Week High
$28.72
$306.67

Technical Indicators

Market Signals
Indicator
ADPT
UNF
Relative Strength Index (RSI) 73.65 25.49
Support Level $23.73 $258.79
Resistance Level N/A $264.88
Average True Range (ATR) 1.06 7.08
MACD 0.37 -1.47
Stochastic Oscillator 97.40 19.35

Price Performance

Historical Comparison
ADPT
UNF

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

About UNF Unifirst Corporation

UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.

Share on Social Networks: